Clinical Trial Update: Reward Sensitivity and Pharmacotherapy for Smoking Cessation [Phase 4]

View source ↗

Summary

Phase 4 study at MD Anderson evaluating reward sensitivity and pharmacotherapy for smoking cessation; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Tobacco Use Cessation | Phase 4 | Status: ACTIVE_NOT_RECRUITING